90420110 - SANGAMO THERAPEUTICS

Information

• Trademark
• 90420110

• Source

• Serial Number

  90420110

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 45 - Legal services

• Filing Date

  December 28, 2020
  4 years ago

• Transaction Date

  February 24, 2025
  5 days ago

• Status Date

  August 09, 2024
  6 months ago

• Published for Opposition Date

  December 28, 2021
  3 years ago

• Location Date

  September 21, 2022
  2 years ago

• Status Code

  734

• Current Location

  INTENT TO USE SECTION

  Employee Name

  LEE,REBECCA ANN

• Attorney Docket Number

  1225327

  Attorney Name

  R. Gwen Peterson

  Law Office Assigned Location Code

  T50

• Owners

  • Sangamo BioSciences, Inc.
  • Sangamo Therapeutics, Inc.

Case File Statements

• DM0000: The mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO".
• GS0051: Biochemicals, biologics, and pharmaceutical preparations, namely, reagents in the nature of engineered proteins for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for clinical medical use and medical use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; Reagents, namely, engineered nucleic acids, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for clinical medical use and medical use
• GS0011: Biochemicals and biologics, namely, engineered proteins in raw material form for gene regulation, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, gene modification, and gene correction, all for use in scientific research, medical pharmaceutical research, scientific agricultural biotechnology research, medical diagnostics research, industrial scientific biotechnology research and all for clinical medical laboratory use and medical laboratory use in the fields of human and animal therapeutics, diagnostics, bioinformatics, genetic diseases, gene therapy, and cell therapy; engineered proteins in raw material form for use in scientific research and analysis relating to genetic diseases, gene therapy, cell therapy, genome editing, and genome regulation; biochemicals and biologics, namely, reagents in the nature of engineered nucleic acids for laboratory use, viral vectors, non-viral vectors, gene therapy vectors, gene editing vectors, genetically modified cells, engineered proteins in raw material form for multiplexed gene editing, mRNA and recombinant adeno-associated virus (AAV) vectors for delivery of therapeutic DNA or mRNA sequences to cells, antibody preparations, CAR T-cell preparations, T-cell preparations, B-cell preparations, Treg preparations, and NK cell preparations, all for use in scientific research, analysis and diagnostics and all for medical clinical laboratory use and medical laboratory use
• GS0451: Licensing of intellectual property rights
• DS0000: "THERAPEUTICS"
• GS0421: Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulation, gene modification, and gene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing

Case File Event Statements

• 12/31/2020 - 4 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 3/17/2021 - 3 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 6/24/2021 - 3 years ago

  4 - ASSIGNED TO EXAMINER Type: DOCK

• 3/18/2021 - 3 years ago

  3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC

• 11/15/2021 - 3 years ago

  9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 11/15/2021 - 3 years ago

  10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 6/30/2021 - 3 years ago

  5 - NON-FINAL ACTION WRITTEN Type: CNRT

• 6/30/2021 - 3 years ago

  6 - NON-FINAL ACTION E-MAILED Type: GNRT

• 6/30/2021 - 3 years ago

  7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 11/15/2021 - 3 years ago

  8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 11/23/2021 - 3 years ago

  11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 12/8/2021 - 3 years ago

  12 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 12/28/2021 - 3 years ago

  13 - PUBLISHED FOR OPPOSITION Type: PUBO

• 12/28/2021 - 3 years ago

  14 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 8/22/2022 - 2 years ago

  18 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/22/2022 - 3 years ago

  15 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM

• 8/22/2022 - 2 years ago

  16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 8/22/2022 - 2 years ago

  17 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 9/19/2022 - 2 years ago

  23 - RESPONSE TO ITU OFFICE ACTION ENTERED Type: IROA

• 8/22/2022 - 2 years ago

  19 - FAX RECEIVED Type: FAXX

• 8/22/2022 - 2 years ago

  24 - SOU EXTENSION 1 FILED Type: EXT1

• 9/15/2022 - 2 years ago

  20 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU

• 9/15/2022 - 2 years ago

  21 - ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST Type: INCE

• 9/19/2022 - 2 years ago

  22 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 2/15/2023 - 2 years ago

  28 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA

• 2/15/2023 - 2 years ago

  29 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN

• 2/20/2023 - 2 years ago

  31 - SOU EXTENSION 2 FILED Type: EXT2

• 9/21/2022 - 2 years ago

  25 - SOU EXTENSION 1 GRANTED Type: EX1G

• 9/22/2022 - 2 years ago

  26 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/15/2023 - 2 years ago

  27 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR

• 2/20/2023 - 2 years ago

  30 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/20/2023 - 2 years ago

  32 - SOU EXTENSION 2 GRANTED Type: EX2G

• 2/22/2023 - 2 years ago

  33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/18/2023 - a year ago

  34 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 8/18/2023 - a year ago

  35 - SOU EXTENSION 3 FILED Type: EXT3

• 8/18/2023 - a year ago

  36 - SOU EXTENSION 3 GRANTED Type: EX3G

• 8/22/2023 - a year ago

  37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 2/22/2024 - a year ago

  38 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/22/2024 - a year ago

  39 - SOU EXTENSION 4 FILED Type: EXT4

• 2/22/2024 - a year ago

  40 - SOU EXTENSION 4 GRANTED Type: EX4G

• 8/9/2024 - 6 months ago

  42 - SOU TEAS EXTENSION RECEIVED Type: EEXT

• 2/23/2024 - a year ago

  41 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/9/2024 - 6 months ago

  45 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA

• 8/9/2024 - 6 months ago

  43 - SOU EXTENSION 5 FILED Type: EXT5

• 2/24/2025 - 5 days ago

  46 - TEAS STATEMENT OF USE RECEIVED Type: EISU

• 8/9/2024 - 6 months ago

  44 - SOU EXTENSION 5 GRANTED Type: EX5G